Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent M Kuenzi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Reviews. Cancer|February 19, 2020
A census of pathway maps in cancer systems biologyBrent M Kuenzi, Trey Ideker
Nature Reviews. Cancer|January 14, 2021
Author Correction: A census of pathway maps in cancer systems biologyBrent M Kuenzi, Trey Ideker
Nature Chemical Biology|June 27, 2018
Unraveling the rewired networkVinayak Palve, Brent M Kuenzi, Uwe Rix
Plos One|September 28, 2017
Escape Excel: A tool for preventing gene symbol and accession conversion errorsEric A Welsh, Paul A Stewart, Brent M Kuenzi, et al.
ACS Chemical Biology|September 22, 2015
Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung CancerNatalia J Sumi, Brent M Kuenzi, Claire E Knezevic, et al.
Molecular Cancer Therapeutics|November 15, 2017
Ceritinib Enhances the Efficacy of Trametinib in <i>BRAF/NRAS</i>-Wild-Type Melanoma Cell LinesDaniel Verduzco, Brent M Kuenzi, Fumi Kinose, et al.
Scientific Reports|January 26, 2019
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemiaBrent M Kuenzi, Lily L Remsing Rix, Fumi Kinose, et al.
Nature Communications|May 6, 2024
De novo generation of multi-target compounds using deep generative chemistryBrenton P Munson, Michael Chen, Audrey Bogosian, et al.
Oncotarget|December 22, 2017
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancerKatie M Mishall, Thomas C Beadnell, Brent M Kuenzi, et al.
Cancer Cell|October 23, 2020
Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer CellsBrent M Kuenzi, Jisoo Park, Samson H Fong, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Reviews. Cancer|February 19, 2020
A census of pathway maps in cancer systems biologyBrent M Kuenzi, Trey Ideker
Nature Reviews. Cancer|January 14, 2021
Author Correction: A census of pathway maps in cancer systems biologyBrent M Kuenzi, Trey Ideker
Nature Chemical Biology|June 27, 2018
Unraveling the rewired networkVinayak Palve, Brent M Kuenzi, Uwe Rix
Plos One|September 28, 2017
Escape Excel: A tool for preventing gene symbol and accession conversion errorsEric A Welsh, Paul A Stewart, Brent M Kuenzi, et al.
ACS Chemical Biology|September 22, 2015
Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung CancerNatalia J Sumi, Brent M Kuenzi, Claire E Knezevic, et al.
Molecular Cancer Therapeutics|November 15, 2017
Ceritinib Enhances the Efficacy of Trametinib in <i>BRAF/NRAS</i>-Wild-Type Melanoma Cell LinesDaniel Verduzco, Brent M Kuenzi, Fumi Kinose, et al.
Scientific Reports|January 26, 2019
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemiaBrent M Kuenzi, Lily L Remsing Rix, Fumi Kinose, et al.
Nature Communications|May 6, 2024
De novo generation of multi-target compounds using deep generative chemistryBrenton P Munson, Michael Chen, Audrey Bogosian, et al.
Oncotarget|December 22, 2017
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancerKatie M Mishall, Thomas C Beadnell, Brent M Kuenzi, et al.
Cancer Cell|October 23, 2020
Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer CellsBrent M Kuenzi, Jisoo Park, Samson H Fong, et al.
Pageof 3